Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study

Leukemia, Published online: 27 August 2019; doi:10.1038/s41375-019-0554-1Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study
Source: Leukemia - Category: Hematology Authors: Source Type: research